Champions Oncology, Inc.

NASDAQ:CSBR

Biotechnology

Healthcare
$4.44 -1.17%

-$0.08 today

Market cap
$61.80M
Beta
0.40
P/E (TTM)
-41.0
EPS (TTM)
-$0.16
52W Low $5.50High $9.63

Volume 0.01M

Average 0.01M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$7.39M

FY 2025 · Annual

Investing Cash Flow

-$389,000.00

FY 2025 · Annual

Financing Cash Flow

$170,000.00

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Net Income334K548K(5.34M)(7.28M)4.7M
Depreciation & Amortization1.18M1.63M2.25M1.87M1.64M
Deferred Income Tax49K01M00
Stock-Based Compensation598K912K864K1.12M654K
Change in Working Capital(4.17M)2.34M4.23M(3.82M)(621K)
Accounts Receivables(2.27M)(2.82M)1.31M(1.99M)(1.44M)
Inventory(1.1M)0000
Accounts Payables(1.25M)974K2.47M465K(1.75M)
Other Working Capital441K4.18M470K(2.3M)2.56M
Other Non-Cash Items323K1.07M952K1.98M1.01M
Operating Cash Flow(1.68M)6.5M3.96M(6.14M)7.39M
Capital Expenditures(3.28M)(2.38M)(2.87M)(836K)(389K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities112K0000
Investing Cash Flow(3.17M)(2.38M)(2.87M)(836K)(389K)
Debt Repayment(174K)00(146K)(150K)
Common Stock Issued1.37M207K85K253K320K
Common Stock Repurchased00(74K)(634K)0
Dividends Paid00000
Other Financing Activities0085K253K0
Financing Cash Flow1.2M207K11K(527K)170K
Effect of Forex Changes0017K00
Net Change in Cash(3.66M)4.32M1.11M(7.5M)7.17M
Free Cash Flow(4.96M)4.11M1.08M(6.97M)7M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$4.7M
+ D&A$1.6M
+ Stock-Based Comp$654.0K
+ Deferred Tax$0
- Working Capital-$621.0K
+ Other Non-Cash$1.0M
= Operating Cash Flow$7.4M
- Capex-$389.0K
= Free Cash Flow$7.0M

Analysis

FY2025 free cash flow is $7.0M. FCF conversion is 148.8% of net income. Operating cash flow was $7.4M, with capex of -$389.0K. The largest bridge item is D&A at $1.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
8-KCurrent reportOct 16, 2026

Does CSBR generate free cash flow?

Champions Oncology, Inc. (CSBR) generated $7.00M of free cash flow in fiscal 2025.

How much operating cash flow does CSBR produce?

Operating cash flow was $7.39M, before capital expenditures of $389,000.00.